Global assessment of IRF8 as a novel cancer biomarker.

McQuaid, Daniel C; Panse, Gauri; Wang, Wei-Lien; Pinkus, Geraldine S; Katz, Samuel G; Xu, Mina L

McQuaid, Daniel C; Panse, Gauri; Wang, Wei-Lien; Pinkus, Geraldine S; Katz, Samuel G; Xu, Mina L.

Afiliación

McQuaid DC; Department of Pathology, Yale New-Haven Hospital, Yale School of Medicine, New Haven, CT, 06510, USA.
Panse G; Department of Pathology, Yale New-Haven Hospital, Yale School of Medicine, New Haven, CT, 06510, USA.
Wang WL; Department of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Katz SG; Department of Pathology, Yale New-Haven Hospital, Yale School of Medicine, New Haven, CT, 06510, USA. Electronic address: samuel.katz@yale.edu.
Xu ML; Department of Pathology, Yale New-Haven Hospital, Yale School of Medicine, New Haven, CT, 06510, USA. Electronic address: mina.xu@yale.edu.

Hum Pathol ; 122: 1-10, 2022 04.

Article en En | MEDLINE | ID: mdl-35085599

Asunto(s)

Biomarcadores de Tumor; Factores Reguladores del Interferón; Neoplasias; Sarcoma; Biomarcadores de Tumor/genética; Humanos; Factores Reguladores del Interferón/genética; Neoplasias/genética; Estudios Retrospectivos; Sarcoma/genética

Palabras clave

Blastic plasmacytoid dendritic neoplasms; Cancer tissue microarrays; IRF8; Myeloid sarcoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Biomarcadores de Tumor / Factores Reguladores del Interferón / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google